Open original FDA record ↗Recall record
- FDA identifier
- Z-1369-2015
- Company in FDA record
- Roche Diabetes Care, Inc.
- FDA classification date
- Apr 2, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Roche Diabetes Care has become aware of an issue with the Accu-Chek Connect diabetes management app that could potentially lead to inaccurate bolus advice being provided to the user. A thorough investigation of the situation revealed that this issue may occur if the user changes the screen orientation of the phone from portrait to landscape or vise versa while looking at the Bolus Advisor or Carb
Source facts
- Action
- Urgent Field Safety Notices were sent to the customer and healthcare professional starting on 10/30/2014. The letter provided a description of the reason for the notification; and recommended that all users should update their app immediately.
- Initiated
- 2014-10-30
- Root cause
- Software design
- Terminated
- 2015-06-08
- Distribution
- There are no US distributors as the affected device is not marketed in the US. The affected device was distributed in Germany, Italy and South Africa. The application has been downloaded total of 644 times (Italy-219, South Africa-24, Germany-401) and there are 113 bolus advice activations.
- Recall number
- Z-1369-2015
- Recall status
- Terminated
- CDRH record ID
- 134687
- FDA classified
- 2015-04-02
- Recall event number
- 70775